Technical Analysis for GMED - Globus Medical, Inc.

Grade Last Price % Change Price Change
D 50.11 -1.26% -0.64
GMED closed down 0.88 percent on Thursday, April 18, 2024, on approximately normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: May 2
*** please verify all earnings dates ***
3 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Bollinger Band Squeeze Range Contraction -1.26%
NR7 Range Contraction -1.26%
Stochastic Reached Oversold Weakness -1.26%
Down 3 Days in a Row Weakness -1.26%
Oversold Stochastic Weakness -1.26%
180 Bearish Setup Bearish Swing Setup -2.13%
Bollinger Band Squeeze Range Contraction -2.13%
MACD Bearish Signal Line Cross Bearish -3.24%
Lizard Bullish Bullish Day Trade Setup -3.24%
Bollinger Band Squeeze Range Contraction -3.24%

   Recent Intraday Alerts

Alert Time
Fell Below Lower Bollinger Band about 2 hours ago
Down 1% about 2 hours ago
60 Minute Opening Range Breakdown about 3 hours ago
Lower Bollinger Band Support about 3 hours ago
Fell Below Previous Day's Low about 5 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Globus Medical, Inc. Description

Globus Medical, Inc., a medical device company, focuses on the design, development, and commercialization of products that promote healing in patients with spine disorders. It offers approximately 100 innovative fusion and disruptive technology products that address an array of spinal pathologies, anatomies, and surgical approaches. The company's innovative fusion products are used in cervical, thoracolumbar, sacral, and interbody/corpectomy fusion procedures to treat degenerative, deformity, tumor, and trauma conditions. Its disruptive technology products provide material improvements to fusion procedures, such as minimally invasive surgical techniques, as well as new treatment alternatives, which include motion preservation technologies, such as dynamic stabilization, total disc replacement and interspinous process spacer products, and advanced biomaterials technologies. The company's products under clinical development include SECURE-C Cervical Artificial Disc, an artificial disc designed to alleviate pain and preserve motion in patients with symptomatic cervical disc disease; ACADIA Facet Replacement System, which allows for an anatomic reconstruction of the facet joint after the degenerated facet is decompressed and removed; and TRIUMPH Lumbar Disc that is used in the treatment of lumbar degenerative disc disease. Globus Medical, Inc. sells its implants and related disposables primarily to hospitals. The company markets and sells its products through sales representatives and independent distributors in the United States and 17 countries internationally. Globus Medical, Inc. was founded in 2003 and is based in Audubon, Pennsylvania.


Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Organ Systems Pain Clinical Development Tumor Technology Products Spine Neurosurgery Healing Biomaterial Deformity Degenerative Disc Disease Fusion Products Neurosurgical Procedures Spine Disorders Vertebra

Is GMED a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 62.88
52 Week Low 43.385
Average Volume 1,050,761
200-Day Moving Average 52.72
50-Day Moving Average 53.19
20-Day Moving Average 52.18
10-Day Moving Average 52.15
Average True Range 1.30
RSI (14) 39.76
ADX 10.47
+DI 20.00
-DI 25.38
Chandelier Exit (Long, 3 ATRs) 50.25
Chandelier Exit (Short, 3 ATRs) 54.56
Upper Bollinger Bands 53.86
Lower Bollinger Band 50.50
Percent B (%b) 0.07
BandWidth 6.44
MACD Line -0.47
MACD Signal Line -0.36
MACD Histogram -0.1141
Fundamentals Value
Market Cap 5.85 Billion
Num Shares 115 Million
EPS 1.47
Price-to-Earnings (P/E) Ratio 34.52
Price-to-Sales 5.90
Price-to-Book 1.72
PEG Ratio 1.80
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 52.09
Resistance 3 (R3) 52.20 51.87 51.86
Resistance 2 (R2) 51.87 51.53 51.81 51.79
Resistance 1 (R1) 51.31 51.32 51.15 51.20 51.71
Pivot Point 50.98 50.98 50.90 50.92 50.98
Support 1 (S1) 50.42 50.64 50.26 50.31 49.79
Support 2 (S2) 50.09 50.43 50.03 49.71
Support 3 (S3) 49.53 50.09 49.64
Support 4 (S4) 49.42